GII.4 Human Norovirus: Surveying the Antigenic Landscape
Human norovirus is the leading cause of viral acute onset gastroenteritis disease burden, with 685 million infections reported annually. Vulnerable populations, such as children under the age of 5 years, the immunocompromised, and the elderly show a need for inducible immunity, as symptomatic dehydr...
Main Authors: | Michael L. Mallory, Lisa C. Lindesmith, Rachel L. Graham, Ralph S. Baric |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/11/2/177 |
Similar Items
-
Bile Facilitates Human Norovirus Interactions with Diverse Histoblood Group Antigens, Compensating for Capsid Microvariation Observed in 2016–2017 GII.2 Strains
by: Michael L. Mallory, et al.
Published: (2020-09-01) -
Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure
by: Lisa C. Lindesmith, et al.
Published: (2022-06-01) -
Immune Imprinting Drives Human Norovirus Potential for Global Spread
by: Lisa C. Lindesmith, et al.
Published: (2022-10-01) -
Identification of Human Norovirus GII.3 Blockade Antibody Epitopes
by: Yufang Yi, et al.
Published: (2021-10-01) -
Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters
by: Camilla A. Strother, et al.
Published: (2023-08-01)